Royalty Pharma Plc (RPRX)
38.67
-1.06
(-2.67%)
USD |
NASDAQ |
Dec 08, 16:00
39.00
+0.33
(+0.85%)
After-Hours: 20:00
Royalty Pharma Total Liabilities (Quarterly): 9.726B for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 4.618B |
| Denali Therapeutics, Inc. | 129.42M |
| Amgen, Inc. | 80.52B |
| Eli Lilly & Co. | 91.08B |
| Zenas BioPharma, Inc. | 125.59M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 19.35B |
| Shareholders Equity (Quarterly) | 6.414B |
| Debt to Equity Ratio | 1.397 |
| Current Ratio | 3.484 |
| Net Debt Paydown Yield | -1.80% |